newsfilter
← Latest News
PR Newswire·

Oramed Letter to Shareholders

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...